CureVac Reports Q1 2025 Financials and Business Update
| Field | Detail |
|---|---|
| Company | Curevac N.V. |
| Form Type | 6-K |
| Filed Date | May 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-results, business-update, 6-K
TL;DR
CureVac dropped Q1 2025 earnings & biz update on 5/20.
AI Summary
On May 20, 2025, CureVac N.V. announced its financial results for the first quarter of 2025 and provided a business update. The company, formerly known as CureVac B.V. until April 10, 2020, is headquartered in Tübingen, Germany.
Why It Matters
This filing provides investors with the latest financial performance and strategic developments from CureVac, a company in the pharmaceutical preparations sector.
Risk Assessment
Risk Level: low — This is a routine financial results and business update filing, not indicating any immediate significant risks.
Key Players & Entities
- CureVac N.V. (company) — Registrant
- CureVac B.V. (company) — Former company name
- May 20, 2025 (date) — Date of press release and filing
- 2025 (date) — Reporting period for financial results
- 001-39446 (other) — Commission File Number
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K filing is to report CureVac N.V.'s financial results for the first quarter of 2025 and provide a business update, as announced in a press release on May 20, 2025.
When did CureVac N.V. change its name from CureVac B.V.?
CureVac N.V. changed its name from CureVac B.V. on April 10, 2020.
What is CureVac N.V.'s principal executive office address?
CureVac N.V.'s principal executive office is located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany.
What is CureVac N.V.'s SIC code?
CureVac N.V.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date for this report?
This report was filed on May 20, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 20, 2025 regarding CureVac N.V..